Anti-Microbial Savior BioteQ Co., Ltd
TWO: 6864.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zhida Wei
- Headquarters
- Kaohsiung, Taiwan
- IPO year
- 2021
- Market cap
- NT$2.2B
- Website
- https://www.ams-bioteq.com
Loading 6864…
Loading profile data…Frequently asked questions about 6864
What does Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) do?
Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical products in Taiwan. The company was founded in 2018 and is based in Kaohsiung, Taiwan.
Where does 6864.TWO trade?
Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) trades on the Taipei Exchange.
What sector is 6864.TWO in?
Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Anti-Microbial Savior BioteQ Co., Ltd?
Zhida Wei is the chief executive officer of Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO).
Where is Anti-Microbial Savior BioteQ Co., Ltd headquartered?
Anti-Microbial Savior BioteQ Co., Ltd is headquartered in Taiwan.
Does 6864.TWO pay a dividend?
Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6864.TWO go public?
Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO) completed its initial public offering in 2021.